These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30230952)

  • 1. Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry.
    Rommer PS; Eichstädt K; Ellenberger D; Flachenecker P; Friede T; Haas J; Kleinschnitz C; Pöhlau D; Rienhoff O; Stahmann A; Zettl UK
    Mult Scler; 2019 Oct; 25(12):1641-1652. PubMed ID: 30230952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the symptoms of multiple sclerosis: a multimodal approach.
    Crayton HJ; Rossman HS
    Clin Ther; 2006 Apr; 28(4):445-60. PubMed ID: 16750459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.
    Skierlo S; Rommer PS; Zettl UK
    Acta Neurol Scand; 2017 Apr; 135(4):394-399. PubMed ID: 27283842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Need for symptomatic management in advanced multiple sclerosis.
    Rønning OM; Tornes KD
    Acta Neurol Scand; 2017 May; 135(5):529-532. PubMed ID: 27357364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multimodal approach to managing the symptoms of multiple sclerosis.
    Crayton H; Heyman RA; Rossman HS
    Neurology; 2004 Dec; 63(11 Suppl 5):S12-8. PubMed ID: 15596731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic therapy of multiple sclerosis.
    Schapiro RT; Langer SL
    Curr Opin Neurol; 1994 Jun; 7(3):229-33. PubMed ID: 8081516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic treatment and management of multiple sclerosis.
    Toosy A; Ciccarelli O; Thompson A
    Handb Clin Neurol; 2014; 122():513-62. PubMed ID: 24507534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey.
    Gustavsen S; Olsson A; Søndergaard HB; Andresen SR; Sørensen PS; Sellebjerg F; Oturai A
    BMC Neurol; 2021 Aug; 21(1):317. PubMed ID: 34399707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic management in multiple sclerosis.
    Samkoff LM; Goodman AD
    Neurol Clin; 2011 May; 29(2):449-63. PubMed ID: 21439453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What is new in symptomatic MS treatment: Part 2-gait disorder and spasticity].
    Henze T; Feneberg W; Flachenecker P; Seidel D; Albrecht H; Starck M; Meuth SG
    Nervenarzt; 2017 Dec; 88(12):1428-1434. PubMed ID: 29063259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual dysfunction levels in iranian women suffering from multiple sclerosis.
    Dehghan-Nayeri N; Khakbazan Z; Ghafoori F; Nabavi SM
    Mult Scler Relat Disord; 2017 Feb; 12():49-53. PubMed ID: 28283107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The application of high-frequency and iTBS transcranial magnetic stimulation for the treatment of spasticity in the patients presenting with secondary progressive multiple sclerosis].
    Korzhova JE; Chervyakov AV; Poydasheva AG; Kochergin IA; Peresedova AV; Zakharova MN; Suponeva NA; Chernikova LA; Piradov MA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2016; 93(5):8-13. PubMed ID: 27801405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spasticity, ataxia and fatigue in multiple sclerosis.
    Kesselring J; Thompson AJ
    Baillieres Clin Neurol; 1997 Oct; 6(3):429-45. PubMed ID: 10101582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
    Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
    Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis.
    Hameau S; Zory R; Latrille C; Roche N; Bensmail D
    Eur J Phys Rehabil Med; 2017 Dec; 53(6):833-840. PubMed ID: 27164538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study.
    Schmidt S; Jöstingmeyer P
    Mult Scler Relat Disord; 2019 Oct; 35():262-269. PubMed ID: 31437741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis.
    Wang G; Marrie RA; Fox RJ; Tyry T; Cofield SS; Cutter GR; Salter A
    Mult Scler Relat Disord; 2018 Feb; 20():16-21. PubMed ID: 29275057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
    Krause I; Kern S; Horntrich A; Ziemssen T
    Mult Scler; 2013 Nov; 19(13):1792-9. PubMed ID: 23635910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?
    Barin L; Salmen A; Disanto G; Babačić H; Calabrese P; Chan A; Kamm CP; Kesselring J; Kuhle J; Gobbi C; Pot C; Puhan MA; von Wyl V;
    Mult Scler Relat Disord; 2018 Oct; 25():112-121. PubMed ID: 30059895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.